# Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

> **NCT00481936** · PHASE1 · TERMINATED · sponsor: **Sesen Bio, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Neoplasms, Glandular and Epithelial

## Interventions

- **DRUG:** VB6-845

## Key facts

- **NCT ID:** NCT00481936
- **Lead sponsor:** Sesen Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Corporate reasons unrelated to safety and efficacy
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481936, "Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00481936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*